| Name | Title | Contact Details |
|---|---|---|
Melissa Gemelli |
Chief Financial Officer | Profile |
Bruce Sparks |
Director Human Resources | Profile |
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.
Daktari Diagnostics is a healthcare solutions company that enables enhanced disease management in both developed and developing countries. Our portable point-of-care diagnostic platform, with built-in wireless connectivity and an intuitive cloud-based data management system, provides the real-time information necessary to improve clinical outcomes for individual patients and support global disease elimination programs. Daktari`s initial products will target viruses of worldwide significance, including Hepatitis C and HIV. The company recently announced a Hepatitis C partnership with Merck & Co (MSD).
DJO Surgical is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Apricus Biosciences Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in San Diego, CA. To find more information about Apricus Biosciences Inc., please visit www.apricusbio.com
Hoosier Oncology Group is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.